➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
AstraZeneca
Baxter
Express Scripts
Harvard Business School

Last Updated: January 19, 2021

DrugPatentWatch Database Preview

Litigation Details for Delcor Asset Corporation v. Glenmark Pharmaceuticals Limited (D. Del. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Delcor Asset Corporation v. Glenmark Pharmaceuticals Limited
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Delcor Asset Corporation v. Glenmark Pharmaceuticals Limited (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-11-15 1 United States Patent Nos. 7,141,237 (“the ’237 patent”) and 7,374,747 (“the ’747 patent”) arising under… INFRINGEMENT OF U.S. PATENT NO. 7,141,237 40. Delcor repeats and realleges…DECLARATORY JUDGMENT OF INFRINGEMENT OF U.S. PATENT NO. 7,141,237 45. Delcor repeats and realleges… THE PATENTS-IN-SUIT 14. The ’237 patent, titled “Pharmaceutical Foam…forth in greater detail in the ’237 patent, the claims of the ’237 patent, incorporated by reference herein External link to document
2017-11-15 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,141,237; 7,374,747. (nmfn) …15 November 2017 1:17-cv-01653-RGA Patent - Abbreviated New Drug Application(ANDA) External link to document
2018-10-31 93 multiple terms in U.S . Patent Nos. 7,141 ,237 ("the '237 patent") and 7,374,747 ("…construction for multiple terms in U.S. Patent Nos. 7,141,237 and 7,374,747. Signed by Judge Richard G… Ill. PATENTS AT ISSUE The '747 patent is a continuation of the '237 patent and the … 237 and ' 747 patents. (D.I. 1 ,r,r 19- 20). Stiefel owns the asserted patents but was joined as …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Harvard Business School
Dow
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.